Josh Pearson

Josh Pearson currently serves as Associate Vice President in the Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics at Merck, a position held since December 2018. Prior to this role, substantial experience was gained at Amgen from April 2006 to December 2018, culminating in the position of Director of Preclinical, overseeing support for protein therapeutics and small molecules across various therapeutic areas. Earlier roles at Amgen included Principal Scientist, Senior Scientist, and Scientist, focusing on pharmacokinetics, ADME, and molecular interactions in inflammation and oncology. Academic credentials include a PhD in Biophysical Enzymology of Drug Metabolizing Enzymes from the University of Washington, complemented by a BS in Biochemistry from California State University, Chico. Early research experience includes a position as a Graduate Research Assistant and a role as Research Scientist at Makel Engineering, Inc.